Abstract: This project aims to develop biomaterials that will promote the long term implantation of encapsulated islets for treatment of diabetes by designing surfaces that directly modulate the function of local immune cells. Type I diabetes is caused by autoimmune attack on insulin- producing beta-cells within pancreatic islets, and affects nearly 3 million patients in the United States. While replacement of beta-cells with healthy donor tissue is a proven treatment modality, widespread clinical success has been limited by the sufficient availability of insulin- producing beta-cells. Transplantation of encapsulated xenograft islets remains a promising approach, but translation to the clinic has remained elusive primarily due to the failure of the encapsulating biomaterial to remain free of fibrosis over long periods of time. The objective of this work is to develop biomaterials that inhibit local immune cells, in order to prevent the inflammatory and ensuing fibrotic response to encapsulated cell therapies. I seek to mitigate the immune response by using a new approach to biomaterial design, where materials are decorated with immunomodulatory molecules that actively deliver tolerizing signals to local immune cells. I hypothesize that coating materials with immunomodulatory molecules will inhibit local inflammation and therefore reduce the host response that results from biomaterial implantation. To test this hypothesis, I will engineer surfaces to display a model immunomodulatory protein at physiologically relevant densities. In addition, I will identify immunomodulatory small molecular weight peptides using phage display screens against known immune cell receptors or directly to immune cells. Identified peptides will be used to modify encapsulation materials and tested in a combinatorial manner within a high throughput in vivo imaging model that allows the real-time evaluation of material biocompatibility within live animals. Identified peptide formulations will be further tested as coatings for encapsulation materials in a xenograft transplant model. This study will investigate an innovative strategy to biomaterial design, where surfaces are engineered to display immunomodulatory molecules that mitigate the host response. This approach may not only benefit cell encapsulation technologies, but also broadly impact the design of biomaterials for medical devices. Public Health Relevance: Transplantation of encapsulation pancreatic islets to treat type I diabetes remains a promising treatment modality, but is hindered by the host inflammatory response to the encapsulating material. This project will explore a new approach to biomaterial design, where materials are tailored to interact with specific receptors expressed on immune cells and inhibit their activation, therefore mitigating the host response to encapsulated islets fr treatment of diabetes.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
NIH Director’s New Innovator Awards (DP2)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-NDIA-C (01))
Program Officer
Drummond, James
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
Biomedical Engineering
Schools of Engineering
United States
Zip Code
Jansen, Lauren E; Amer, Luke D; Chen, Esther Y-T et al. (2018) Zwitterionic PEG-PC Hydrogels Modulate the Foreign Body Response in a Modulus-Dependent Manner. Biomacromolecules 19:2880-2888
Herrera, Vanessa; Hsu, Ssu-Chieh Joseph; Rahim, Maha K et al. (2018) Pushing the limits of detection for proteins secreted from single cells using quantum dots. Analyst :
Chen, E Y; Chu, S; Gov, L et al. (2017) CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic co-glycolic acid) microparticles and films. J Mater Chem B 5:1574-1584
Hsieh, Jessica Y; Smith, Tim D; Meli, Vijaykumar S et al. (2017) Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen. Acta Biomater 47:14-24
Kim, Yoon Kyung; Chu, Shu-Hui; Hsieh, Jessica Y et al. (2017) Incorporation of a Ligand Peptide for Immune Inhibitory Receptor LAIR-1 on Biomaterial Surfaces Inhibits Macrophage Inflammatory Responses. Adv Healthc Mater 6:
Wang, Tingting; Luu, Thuy U; Chen, Aaron et al. (2016) Topographical modulation of macrophage phenotype by shrink-film multi-scale wrinkles. Biomater Sci 4:948-52
Alfonso-GarcĂ­a, Alba; Smith, Tim D; Datta, Rupsa et al. (2016) Label-free identification of macrophage phenotype by fluorescence lifetime imaging microscopy. J Biomed Opt 21:46005
McWhorter, Frances Y; Smith, Tim D; Luu, Thuy U et al. (2016) Macrophage secretion heterogeneity in engineered microenvironments revealed using a microwell platform. Integr Biol (Camb) 8:751-60
Smith, Tim D; Tse, Margaret J; Read, Elizabeth L et al. (2016) Regulation of macrophage polarization and plasticity by complex activation signals. Integr Biol (Camb) 8:946-55
McWhorter, Frances Y; Davis, Chase T; Liu, Wendy F (2015) Physical and mechanical regulation of macrophage phenotype and function. Cell Mol Life Sci 72:1303-16

Showing the most recent 10 out of 15 publications